National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey

Dursun, Adile BernaBavbek, SevimMısırlıgil, ZeynepErdener, F.Büyüköztürk, SunaAydın, ÖmürGemicioğlu, BilunBayrak, P.Erkekol, Ferda ÖnerYıldırım, ZekiÇilli, AykutBoz, Bingol A.Alpaydın, Özgen A.Karakoç, Bingol G.Görgüner, MetinKarakaya, GülIşık, RüveydaBakırtaş, Arzu2022-03-172022-03-172011-06Dursun, A. vd. (2011). "National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey". Allergy, 66(Supplement 94), Special Issue SI, 675-676.0105-45381398-9995http://hdl.handle.net/11452/25149Bu çalışma, 11-15 Haziran 2011 tarihleri arasında İstanbul[Türkiye]’da düzenlenen 30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessAllergyImmunologyNational safety data of post-marketing use of omalizumab in severe persistent asthma in TurkeyMeeting Abstract00032946220408067567666Supplement 94AllergyImmunology